Réaction #167

ord-57be3c43ca2f40d482cab5a1bd42b5d5

Équation de réaction

Cc1c(Br)cccc1[N+](=O)[O-]
Cc1c(Br)cccc1[N+](=O
CC(=O)N1CCNCC1
CC(=O)N1CCNCC1
CC(=O)N1CCN(c2cccc([N+](=O)[O-])c2C)CC1
CC(=O)N1CCN(c2cccc([
Rendement 98.5%

Solvants

Conditions de réaction

Température
100°CELSIUS

Mode opératoire

1-bromo-2-methyl-3-nitrobenzene (500 mg, 2.31 mmol), (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (201 mg, 0.35 mmol) and cesium carbonate (1131 mg, 3.47 mmol) and diacetoxypalladium (52.0 mg, 0.23 mmol) were dissolved in toluene (10 mL) and sealed into a microwave tube degazed and purged with argon. The reaction was heated to 100 °C, over a period of 12 hours. The reaction mixture was cooled down to room temperature, filtered and the residue was evaporated. The crude product was purified by flash chromatography on silica gel eluting with 0 to 10% methanol in dichloromethane. The solvent was evaporated to dryness to afford 1-(4-(2-methyl-3-nitrophenyl)piperazin-1-yl)ethanone (600 mg, 98 %) as a solid.

Source

750 AstraZeneca ELN dataset